https://www.selleckchem.com/pr....oducts/paeoniflorin.
71 (0.63-0.8, F ≥ 3 = 0.82 (0.74-0.9, F4 = 0.89 (0.76-1.]. However, combining sCD163 and TE did not improve the AUROCs significantly [F ≥ 2 = 0.79 (0.72-0.86), F ≥ 3 = 0.85 (0.78-0.92), F4 = 0.97 (0.93-1.]. In the Swedish cohort, TE showed a closer association with fibrosis (rho = 0.73, p less then 0.001) than sCD163 (rho = 0.43, p less then 0.001) and sMR (rho = 0.46, p less then 0.001). TE predicted fibrosis well [F ≥ 2 = 0.88 (0.80-0.97), F ≥ 3 = 0.90 (0.83-0.97), F4 = 0.87 (0.78-0.96)], whereas sCD163 did not (best AURO